Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response-Reference-Cited by-同舟云学术

Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response

Published:2020-08 Issue:4 Volume:10 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Li Jingjing¹,Wei Qing¹^ORCID,Wu Xiaoying²,Sima Jun³,Xu Qi¹,Wu Mengmeng²,Wang Fufeng²,Mou Haibo⁴,Hu Hanguang⁵,Zhao Jianguo⁶,Li Da⁷,Hu Jinlin⁸,Zhang Lingnan⁹,Zhu Xiu⁸,Chen Lei¹,Luo Cong¹,Yan Junrong²,He Jiachen²,Ma Yutong²,Shao Yang²,Wu Wei⁸,Ying Jieer¹

Affiliation:

1. Department of Abdominal Medical Oncology Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Cancer and Basic Medicine (IBMC) Chinese Academy of Sciences Hangzhou Zhejiang China

2. Nanjing Geneseeq Technology Inc. Nanjing China

3. Department of General Surgery Hangzhou Redcross Hospital Hangzhou China

4. Department of Medical Oncology Shulan (Hangzhou) Hospital Hangzhou China

5. Department of Medical Oncology Second Affiliated Hospital, Zhejiang University College of Medicine Hangzhou China

6. Department of Oncology Shaoxing People's Hospital, Shaoxing Hospital of Zhejiang University Shaoxing China

7. Department of Medical Oncology Sir Run Shaw Hospital, Zhejiang University School of Medicine Hangzhou China

8. Department of Pathology Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Cancer and Basic Medicine (IBMC) Chinese Academy of Sciences Hangzhou Zhejiang China

9. Radiology Department Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) Institute of Cancer and Basic Medicine (IBMC) Chinese Academy of Sciences Hangzhou Zhejiang China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.118

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

3. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

4. Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1113, FUGA-BT)

5. Comprehensive genomic profiling identifies novel genetic predictors of response to anti‐PD‐(L)1 therapies in non‐small cell lung cancer;Fang W;Clin Cancer Res,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer;Cancer Management and Research;2024-07

2. Impact of sarcopenia on the short-term and long-term outcomes of intrahepatic cholangiocarcinoma undergoing hepatectomy: A multi-center study;European Journal of Surgical Oncology;2024-04

3. Comprehensive characterization of PKHD1 mutation in human colon cancer;Cancer Medicine;2024-01

4. Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis;Cells;2023-08-19

5. Construction of inflammatory associated risk gene prognostic model of NSCLC and its correlation with chemotherapy sensitivity;Annals of Medicine;2023-04-21